Development of a Serogroup B Specific Footrot Vaccine with Montanide ISA 61 VG Adjuvant for Prophylactic and Therapeutic Use in Sheep
Authors:
- Arham QuraishiAQArham Quraishi
- Isfaqul HussainIHIsfaqul Hussain
- Shaheen FarooqSFShaheen Farooq
- Zahid Amin KashooZKZahid Amin Kashoo
- Najeeb Ul TarfainNTNajeeb Ul Tarfain
- Sabia QureshiSQSabia Qureshi
- Mir Nadeem HassanMHMir Nadeem Hassan
- Mohd Altaf BhatMBMohd Altaf Bhat
- Mansoor Nabi MirMMMansoor Nabi Mir
- Syed Mudasir AhmadSASyed Mudasir Ahmad
- Syed Akram HussainSHSyed Akram Hussain
- Zahoor Ahmad WaniZWZahoor Ahmad Wani
Open Access
- 7 February 2025
- journal article
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (1) , 255-262
Abstract
Virulent footrot represents as a significant contagious ailment affecting sheep, with Dichelobacter nodosus being the primary agent responsible for transmitting the disease. Vaccinations and various management practices are utilized to control the disease. In this study, we cultured D. nodosus in broth culture under reducing conditions and formulated a vaccine using Montanide oil as adjuvant. The efficacy of the vaccine was assessed in sheep to determine its ability to elicit an effective immune response and its therapeutic potential. D. nodosus serogroup B (JKS-07B strain) was grown in a modified TAS broth and a whole cell killed vaccine was prepared using 1.5 × 109 cells per dose, along with the oil adjuvant Montanide ISA 61 VG. The vaccine trial was conducted in sheep and two doses of the vaccine were given subcutaneously with a 30 days interval between the doses. The serum antibody titers in the vaccinated animals were measured at 0, 30, 60, 90, 120, and 150 days post-vaccination using the microplate agglutination test. Protective antibody titers (≥ 3000) were achieved by the 30th day following the primary vaccination in all animals, reaching their peak at the 60th day. The protective level of antibody titers was maintained up to 120 days following the primary vaccination. The vaccine also demonstrated a therapeutic effect in animals that were clinically affected. Animals with a lesion score of 2 took 18-21 days for recovery, while those with a lesion score of 3-4 took 40-47 days to recover from lameness.Keywords
This publication has 37 references indexed in Scilit:
- Determination of prevalence, serological diversity, and virulence of Dichelobacter nodosus in ovine footrot with identification of its predominant serotype as a potential vaccine candidate in J&K, IndiaTropical Animal Health and Production, 2019
- A review of footrot in sheep: Aetiology, risk factors and control methodsLivestock Science, 2013
- Identification of two new serotypes within serogroup B of Dichelobacter nodosusAnaerobe, 2012
- Thiotrichales ord. nov.2005
- Serogroup specific single and multiplex PCR with pre-enrichment culture and immuno-magnetic bead capture for identifying strains of D. nodosus in sheep with footrot prior to vaccinationMolecular and Cellular Probes, 2002
- Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigensVeterinary Immunology and Immunopathology, 1994
- Treatment of ovine foot-rot by vaccination with the specific aetiological agent Bacteroides nodosusComparative Immunology, Microbiology and Infectious Diseases, 1979
- Vaccination against ovine foot-rotJournal of Comparative Pathology, 1971
- The aetiology and pathogenesis of ovine foot-rotJournal of Comparative Pathology, 1969
- Ovine interdigital dermatitisJournal of Comparative Pathology, 1967